Media

FeaturesOctober 15, 2021

“We're Just Scratching the Surface of What Can Be Done.”

Chief Medical Officer, Dr. Reid Robison opened the PSYCH Investor Summit with a keynote address presenting Novamind’s positioning and the rise and rollout of psychedelic medicine.

OpinionOctober 12, 2021

Psychedelics, Mindfulness, and Contemplative Practices

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison are joined for the second time by Dr. Paul Theilking, MD. Paul is a psychiatrist, zen practitioner, and Chief Scientific Officer at Novamind.

FeaturesOctober 08, 2021

Addressing Mental Health through Emerging Therapies

CEO Yaron Conforti joins a panel of industry leaders at the Benzinga Healthcare Small Cap Conference for this informative discussion.

FeaturesOctober 07, 2021

Mental Healthcare for Patients with Chronic or Serious Illness

Psychedelic Palliative Care is a specialized program designed to provide access to psychedelic medicine and support for people with mental and emotional stress associated with chronic or serious illness. This innovative program combines psychotherapy, psychedelic medicine, mindfulness and group support in a safe and nurturing environment for patients and their families.

FeaturesOctober 06, 2021

Novamind Today and Into the Future

CEO Yaron Conforti at the Benzinga Healthcare Small Cap Conference on the progress we’ve been making to increase access to psychedelic medicine.

OpinionOctober 05, 2021

Self Compassion, Forgiveness, and Judgment Detox

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison discuss self-compassion, why it is so hard (but so important) to forgive, and how to detox from judgement.